Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

CareRx (CRRX) Stock Price & Analysis

86 Followers

CRRX Stock Chart & Stats

CA$3.17CA$0.01(0.32%)
At close: 4:00 PM EST
C$3.1C$3.2C$3.3C$3.4Aug 17Aug 31Sep 14Sep 28Oct 13Oct 26Nov 9
Day’s Range
CAD 3.00 - CAD 3.23
52-Week Range
CAD 3.00 - CAD 4.00
Previous Close
CAD 3.16
Volume
N/A
Average Volume (3M)
69.23K
Market Cap
CAD 200.54M
Enterprise Value
CAD 274.96M
Total Cash (Recent Filing)
CAD 10.65M
Total Debt (Recent Filing)
CAD 77.61M
Price to Earnings (P/E)
7.8
Beta
0.06
Next Earnings
Mar 10, 2027 (Est.)
EPS Estimate
0.04
Next Dividend Ex-Date
Dec 14, 2026
Dividend Yield
2.59%

Bulls Say, Bears Say

Bulls Say

Profitability Turnaround

The transition from several years of losses to sustained profitability improves CareRx’s ability to fund operations and reinvest in growth. Stable net and EBITDA margins also indicate that the expanded platform is generating meaningful earnings power, although continued execution will determine how durable the improvement becomes.

Expanding Serviced-bed Platform

Growth in serviced beds directly expands the recurring operating base for CareRx’s pharmacy and clinical services. The successful national onboarding also demonstrated network capacity and supports further organic growth by showing that the company can absorb sizeable contracts across multiple communities.

Improved Leverage And Financing Flexibility

Lower leverage and a longer-term credit structure give CareRx more financial flexibility than its stressed 2022–2023 position. Dedicated funding capacity can support acquisitions and investment while the 0.9x net-debt-to-EBITDA level provides a comparatively conservative base for pursuing measured growth.

Bears Say

Slowing Cash-flow Momentum

Positive cash generation remains an important strength, but the recent decline in operating cash flow and TTM free cash flow reduces the funds available for debt reduction, acquisitions and shareholder returns. Historically moderate debt coverage further limits flexibility if operating performance weakens.

Margin Pressure From Onboarding And Labor Costs

Costs incurred before newly onboarded beds reach full productivity can temporarily dilute margins and make earnings conversion less predictable. Although management expects efficiency benefits from the completed onboarding, labor and implementation timing remain important factors for sustaining profitability over coming quarters.

Lumpy Timing Of New Business Wins

Uneven contract timing can make revenue and bed growth less predictable even when the underlying pipeline is attractive. Delayed wins may leave capacity and onboarding investments ahead of revenue, creating quarter-to-quarter variability and making sustained growth dependent on consistent execution across new customers.

CareRx News

CRRX FAQ

What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$3.00 and its highest was C$4.00 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$200.54M.
When is CareRx’s upcoming earnings report date?
CareRx’s next earnings report is estimated for Mar 10, 2027 (not yet confirmed), which is in 118 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Nov 04, 2026. The company reported C$0 earnings per share for the quarter, missing the consensus estimate of C$0.037 by -C$0.037.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a quarterly dividend of C$0.022 which represents an annual dividend yield of 2.59%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.04.
How many shares outstanding does CareRx have?
CareRx has 63,514,038 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of C$0 in its last earnings report, missing expectations of C$0.037. Following the earnings report the stock price went down -6.765%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology